![Halbe Breite 1000x667 LETYBO v24](/assets/press/Halbe_Breite_1000x667_LETYBO_v24__FitMaxWzExMzgsOTEwXQ.jpg)
Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar lines
By adding its own botulinum toxin to the already broad portfolio Croma catapults itself to a new level within the aesthetic industry.
By adding its own botulinum toxin to the already broad portfolio Croma catapults itself to a new level within the aesthetic industry.